Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine TAP Block in Laparoscopic Colonic Surgery
NCT02219542Phase 4Completed
- Sponsor
- China Medical University
- Start
- Aug 2014
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine, sponsored by China Medical University. Primary endpoint: Cytokine level at 24 hours. Started Aug 2014; status: completed.
02
Drugs
ropivacaine
Beyond the preview
Go deeper on NCT02219542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219542.